Koyfin Home > Directory > Health Care > Abiomed Inc

Abiomed Inc Price Chart ABMD

Historical daily share price chart and data for Abiomed Inc since 1987 adjusted for splits and dividends. The latest closing price for Abiomed Inc as of November 27, 2020 is $271.9.
  • In 2020 the stock opened at $172.51 and closed at $271.90 for a gain of 37% YTD.
  • In 2019 the stock opened at $315.94 and closed at $170.59 for a loss of -85%.
  • In 2018 the stock opened at $188.13 and closed at $325.04 for a gain of 42%.
  • In 2017 the stock opened at $112.56 and closed at $187.41 for a gain of 40%.
View Chart On Koyfin

Abiomed Inc Summary

Stock Symbol: ABMD

Abiomed Inc Company Info

Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; and Impella CP, a device used by interventional cardiologists to support patients in the cath lab and cardiac surgeons in the heart surgery suite. It also provides Impella 5.0 and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; Impella RP, a percutaneous catheter-based axial flow pump; Impella SmartAssist platform that includes optical sensor technology for improved pump positioning and the use of algorithms that enable improved native heart assessment during the weaning process; and Impella Connect, a cloud-based technology that enables secure, cloud-based, and remote viewing of the Automated Impella Controller for physicians and hospital staffs. In addition, the company engages in the development of Impella XR Sheath, a sheath designed to expand and recoil to all for ease of use upon insertion of an Impella heart pump and minimize the size of the arteriotomy; Impella BTR, a percutaneous micro heart pumps with integrated motors and sensors; and Impella ECP pump that is designed for blood flow of greater than three liters per minute. It sells its products through direct sales and clinical support personnel in the United States, Canada, Europe, and Asia. The company was founded in 1981 and is headquartered in Danvers, Massachusetts.
Market Cap
Dividend Yield
0 %
Beta vs SPX
Short Interest
205.05 %
30D Volatility
Hedge Fund Held
8.53 %

Last 10 Days of ABMD Prices